logo
Select company
Select metric
$ 14.81MInterest Expense
VS
Market
39
Sector
19
Industry
8
History
-
$ 18Close
$ 3.93 - $ 21.42 52-Week Range
Ticker Information

Ticker

URGN

Company Name

UROGEN PHARMA LTD

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

UROGEN PHARMA LTD - Interest Expense Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

URGN - Int. Exp. Historical data
DateInterest Expense
6/30/2025$ 14.81M
3/31/2025$ 14.14M
12/31/2024$ 12.52M
9/30/2024$ 12.21M
6/30/2024$ 13.31M
3/31/2024$ 13.61M
12/31/2023$ 14.71M
9/30/2023$ 14.35M
6/30/2023$ 13.23M
3/31/2023$ 11.71M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • UROGEN PHARMA LTD's latest trailing twelve months (TTM) Int. Exp. stands at $ -4.33M.
  • Over the past 5 years, UROGEN PHARMA LTD's average Int. Exp. has been $ 7.34M.
  • The median Int. Exp. for UROGEN PHARMA LTD during this period was $ 10.07M
  • UROGEN PHARMA LTD reached its highest Int. Exp. over the past 5 years at $ 14.81M.
  • The lowest Int. Exp. recorded by UROGEN PHARMA LTD in the same timeframe $ -4.33M

UROGEN PHARMA LTD's Int. Exp. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Int. Exp. Benchmarks
CompanyInt. Exp.
NRIX : NURIX THERAPEUTICS INC $ 0SNDX : SYNDAX PHARMACEUTICALS INC $ 20.74MGYRE : GYRE THERAPEUTICS INC $ 0CRMD : CORMEDIX INC $ 36.69KNAGE : NIAGEN BIOSCIENCE INC $ 0ZYME : ZYMEWORKS INC $ 0PHAT : PHATHOM PHARMACEUTICALS INC $ 72.67MTBPH : THERAVANCE BIOPHARMA INC $ 2.58MWVE : WAVE LIFE SCIENCES LTD $ 0KURA : KURA ONCOLOGY INC $ 1.59M

Definition of Interest Expense

[Income Statement] Interest expense is the cost incurred by a business for borrowing funds.

URGN - Interest Expense, Last 5 years

$ -4.33M

Minimum

Sep 30, 2020

$ 14.81M

Maximum

Jun 30, 2025

$ 7.34M

Average

$ 10.07M

Median

Int. Exp. Benchmark Analysis

The chart above depicts the distribution of Int. Exp. for companies in the Total Stock Market. The average Int. Exp. of the companies is $ 2.79M with a standard deviation of $ 5.55M.
The following table provides additional summary stats:
Int. Exp. in the Market:
filtered constituents2.73K
min$ -15.41M
max$ 23.06M
average$ 2.79M
median$ 19.42K
std$ 5.55M